Migrant fathers and their attitudes to potential male hormonal contraceptives.

The purpose of this study was to assess potential uptake of male hormonal contraception (MHC) in migrant fathers in a post-partum setting, and to compare them to Australian-born fathers. It was a cross-sectional study of a convenience sample from the post-natal ward of a tertiary level obstetric hospital. Seventy-six English-speaking fathers born in South-East Asia or on the Indian subcontinent were surveyed and their responses compared with those provided by 118 Australian-born participants from a previous study. The main outcome measures were acceptability of potential male hormonal contraception on a 5-point scale, and preferred mode of administration. Information on past and future intended contraceptive use, including existing male forms of contraception, was also compared with data collected from the group of Australian-born men. Only 13.6% (95%CI: 5.8-21.4) of migrant fathers would definitely or probably consider trying MHC compared with 47.5% (95%CI: 38.5-56.5) of Australian-born fathers (chi-square, p < 0.001). There were significant differences in desired mode of administration in potential 'triers' from both groups, as well as in attitudes to existing contraception. Two-yearly injection was the most popular method of administration in migrants, with 38.3% of 'triers' listing it as their first choice (compared with 21.4% in published data on Australian-born men; chi-square, p = 0.038). We conclude that migrant groups are less enthusiastic about novel potential MHC. The influence of education on acceptance of this contraceptive possibility needs to be assessed.

Will Australian men use male hormonal contraception? A survey of a postpartum population.

AIM: To survey the attitudes of a population of Australian men to potential use of male hormonal contraception (MHC). DESIGN: Survey of male partners of women who had recently given birth. Men were approached while visiting their female partners on the ward. PARTICIPANTS: 118 out of 148 Australian-born English-speaking men who were approached. SETTING: Postnatal ward of Monash Medical Centre (a public teaching hospital in Melbourne), between October 2000 and April 2001. MAIN OUTCOME MEASURE: Attitudes towards potential use of MHC, rated on a five-point scale. RESULTS: 89/118 men surveyed (75.4%; 95% Cl, 67.7%-83.2%) indicated that they would consider trying MHC if it were available. The three most popular choices for method of administration of MHC were (in descending order) an oral pill, a three-monthly injection, or a two-yearly injection. A statistically significant association was found between acceptability of vasectomy and acceptability of MHC (70.5% of men who indicated they would try MHC [MHC "triers"] found vasectomy acceptable versus 44.5% of MHC "non-triers"; P = 0.011). Triers reported a higher rate of approval of MHC by their female partners than non-triers (79.8% v 13.8%, respectively; P < 0.0001). CONCLUSIONS: MHC appears to be acceptable to a majority of Australian men when surveyed in a postpartum context. Attitudes of men towards existing male contraception, as well as the attitudes of their partners, appear to exert a strong influence on acceptability of MHC.